# Texan Allergy & Sinus Center Mountain Cedar Intra-Lymphatic Immunotherapy Study

> **NCT03682965** · PHASE2 · COMPLETED · sponsor: **Christopher Thompson, MD** · enrollment: 21 (actual)

## Conditions studied

- Allergic Rhinitis Due to Tree Pollen
- Allergic Conjunctivitis
- Allergic Rhinoconjunctivitis

## Interventions

- **BIOLOGICAL:** Intra-lymphatic allergenic extract
- **BIOLOGICAL:** Intra-lymphatic placebo

## Key facts

- **NCT ID:** NCT03682965
- **Lead sponsor:** Christopher Thompson, MD
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-09-28
- **Primary completion:** 2019-03-06
- **Final completion:** 2019-04-29
- **Target enrollment:** 21 (ACTUAL)
- **Last updated:** 2021-04-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03682965

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03682965, "Texan Allergy & Sinus Center Mountain Cedar Intra-Lymphatic Immunotherapy Study". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03682965. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*